Episode 15: Adding stereotactic radiotherapy to abiraterone acetate significantly delays disease progression in oligometastatic CRPC patients: the ARTO trial
In this new episode of ‘What’s New Doc’ in Prostate cancer, Prof Bertrand Tombal from the Cliniques Universitaires Saint-Luc in Brussels and Prof Steven Joniau from the University Hospitals Leuven discuss the results of the phase II ARTO trial, evaluating